LSLCF yields 74074.07% · JNJ yields 2.13%● Live data
📍 LSLCF pulled ahead of the other in Year 1
Combined, LSLCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LSLCF + JNJ for your $10,000?
Lachlan Star Limited, together with its subsidiaries, engages in the exploration of mineral properties in Australia. It explores for gold, silver, copper, nickel, cobalt, lead, zinc, and PGE deposits. The company holds 100% interests in the Princhester Magnesite project that includes two granted mining leases located to the northwest of Rockhampton, Queensland; and the Killaloe gold project consists of two contiguous exploration licenses and the separate Buldania mining license covering an area of approximately 94 square kilometers located in the Eastern Goldfields, Western Australia. It also holds 75% interest in the Koojan project located in the New Norcia region, Western Australia. The company was formerly known as Toodyay Resources Limited and changed its name to Lachlan Star Limited in November 2007. Lachlan Star Limited was incorporated in 1970 and is based in West Perth, Australia.
Full LSLCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.